Skip to main content
. 2019 Oct;60(10):1406–1413. doi: 10.2967/jnumed.118.225235

FIGURE 3.

FIGURE 3.

Median bone marrow absorbed doses after treatment fraction 1 estimated using planar method and 4 hybrid methods for all patients (A), patients with skeletal metastases (B), and patients without skeletal metastases (C).